Treatment change for prostate cancer: study reveals benefit of second PSMA PET
A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of prostate cancer patients whose first scan was negative, according to new research.
Read the full articleYou might also wanna read
Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients
A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negativ

2nd PET scan changes treatment for nearly half of prostate cancer patients
Managing recurrent prostate cancer after first-line treatment remains a key clinical challenge, experts write in The Journal of Nuclear Medi
Phase 3 trial: PSMA-PET-CT may help some high-risk men avoid prostate biopsy
Phase 3 data suggest PSMA-PET-CT could reduce unnecessary prostate biopsies in selected high-risk men, though longer follow-up is needed.
PSMA PET-Guided Progression-Directed Radiotherapy for Oligoprogressive Prostate Cancer
Conditions : Oligoprogressive Prostate Cancer; Metastatic Prostate Cancer Interventions : Radiation: Progression-Directed Radiotherapy Spons
Earlier Screening May Reduce Metastatic Prostate Cancer
Earlier prostate cancer screening and lower baseline PSA levels were associated with markedly lower rates of metastatic prostate cancer amon
Study: Imaging scans detect prostate cancer progression missed by stable PSA levels
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of prostate-specific an

Comments
Sign in to join the conversation.
No comments yet. Be the first.